These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 19070815)
1. [Physiopathology, diagnosis and management of bone metastases from prostate cancer]. Lebret T; Méjean A Prog Urol; 2008 Nov; 18 Suppl 7():S349-56. PubMed ID: 19070815 [TBL] [Abstract][Full Text] [Related]
2. Bone-directed treatments for prostate cancer. Saad F Hematol Oncol Clin North Am; 2006 Aug; 20(4):947-63. PubMed ID: 16861125 [TBL] [Abstract][Full Text] [Related]
3. Natural history and treatment of bone complications in prostate cancer. Saad F; Clarke N; Colombel M Eur Urol; 2006 Mar; 49(3):429-40. PubMed ID: 16431012 [TBL] [Abstract][Full Text] [Related]
4. The role of bisphosphonates in the management of bone metastases in prostate cancer. Saad F; Chi K; Fleshner N Can J Urol; 2004 Oct; 11(5):2376-82. PubMed ID: 15576002 [TBL] [Abstract][Full Text] [Related]
6. Multidisciplinary management of bone complications in prostate cancer and optimizing outcomes of bisphosphonate therapy. Saad F; Sternberg CN Nat Clin Pract Urol; 2007 Feb; 4 Suppl 1():S3-13. PubMed ID: 17264863 [TBL] [Abstract][Full Text] [Related]
7. [How to manage bone metastasis in prostate cancer. A case report]. Lebret T; Salomon L; Richaud P; Fizazi K; Gaillard S; Benchikh El Fegoun A Prog Urol; 2010 Mar; 20 Suppl 1():S72-6. PubMed ID: 20493451 [TBL] [Abstract][Full Text] [Related]
8. [Physiopathology and new therapeutic strategies in the management of bone metastases of prostate cancer]. Lebret T; Méjean A; Houédé N Prog Urol; 2011 May; 21(5):301-7. PubMed ID: 21514531 [TBL] [Abstract][Full Text] [Related]
9. [The application advances of bisphosphonates in bone metastasis]. Liang P Zhongguo Gu Shang; 2008 Jun; 21(6):480-2. PubMed ID: 19108448 [TBL] [Abstract][Full Text] [Related]
10. Targeting factors involved in bone remodeling as treatment strategies in prostate cancer bone metastasis. Vessella RL; Corey E Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6285s-6290s. PubMed ID: 17062715 [TBL] [Abstract][Full Text] [Related]
11. [Biphosphonates in the treatment of bone metastasis of prostatic cancer]. Paule B; Cicco A Prog Urol; 2001 Dec; 11(6):1205-12. PubMed ID: 11859653 [TBL] [Abstract][Full Text] [Related]
12. Targeting of therapeutic agents to bone to treat metastatic cancer. Bagi CM Adv Drug Deliv Rev; 2005 May; 57(7):995-1010. PubMed ID: 15876400 [TBL] [Abstract][Full Text] [Related]
13. Evaluating bone metastases. Albert K Clin J Oncol Nurs; 2007 Apr; 11(2):193-7. PubMed ID: 17573268 [No Abstract] [Full Text] [Related]
14. Current trials using bone-targeting agents in prostate cancer. Tu SM; Lin SH Cancer J; 2008; 14(1):35-9. PubMed ID: 18303481 [TBL] [Abstract][Full Text] [Related]
15. Bone metastases: Part I--Pathophysiology. Fisher G; Mayer DK; Struthers C Clin J Oncol Nurs; 1997 Apr; 1(2):29-35. PubMed ID: 9410649 [TBL] [Abstract][Full Text] [Related]
16. Medical management of skeletal metastasis. Yu MK; Buys SS Neurosurg Clin N Am; 2004 Oct; 15(4):529-36, xi. PubMed ID: 15450887 [TBL] [Abstract][Full Text] [Related]
17. [The role of bisphosphonate in the treatment of bone metastases from prostate cancer]. Sallami S; Ben Rhouma S; Cherif K; Benrais N; Horchani A Tunis Med; 2012 Jul; 90(7):507-11. PubMed ID: 22811222 [TBL] [Abstract][Full Text] [Related]
18. Preservation of bone health in prostate cancer. Lattouf JB; Saad F Curr Opin Support Palliat Care; 2007 Oct; 1(3):192-7. PubMed ID: 18685362 [TBL] [Abstract][Full Text] [Related]
19. New results from the use of bisphosphonates in cancer patients. Coleman R; Gnant M Curr Opin Support Palliat Care; 2009 Sep; 3(3):213-8. PubMed ID: 19561507 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of tumor osteopathy in cancer of the prostate]. Alcover J; Fernández-Conde M; Carrere W; Serrallach M; Carretero P Actas Urol Esp; 1994 May; 18 Suppl():409-16. PubMed ID: 8073927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]